相关实验视频
Updated: May 29, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.4K
血清和尿液中由乙氨基酸衍生的神经毒素 (EDN) 水平预测严重喘时的生物反应
Yu Ri Kang1, Hyunkyoung Kim2, Chae Eun Lee2
1Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea.
The World Allergy Organization journal
|February 3, 2025
概括
血中乙氨基酸细胞数量和乙氨基酸衍生神经毒素 (EDN) 水平可以预测严重喘患者的治疗反应. EDN 显示出与乙酸细胞计数相似的预测能力,但为了更广泛的应用,需要进一步的研究.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 生物标志物发现发现
背景情况:
- 乙氨基是过敏炎症和喘严重性的关键参与者.
- 血中乙氨基酸细胞数量是标准标记物,但局限性需要探索诸如乙氨基酸细胞衍生神经毒素 (EDN) 等替代品.
研究的目的:
- 评估血中乙氨基酸细胞数和EDN作为预测严重喘治疗反应的生物标志物的临床意义.
- 在接受生物疗法的患者中,比较血中乙氨基酸细胞数量,血液EDN和尿液EDN的预测能力.
主要方法:
- 一项为期24周的研究涉及56名严重喘患者,这些患者接受了梅波利祖马布 (mepolizumab),复利祖马布 (reslizumab) 或复利祖马布 (dupilumab) 的治疗.
- 用ELISA测试来测量生物标志物水平.
- 统计分析将生物标志物与临床特征相关联,如恶化率和肺功能.
主要成果:
- 在血清EDN水平,血中乙氨基酸细胞数量和治疗反应之间发现了强烈的相关性.
- EDN的预测能力与血中乙氨基酸细胞数量相当.
- 不同的生物疗法根据基线的乙氨基和EDN水平显示出不同的疗效.
结论:
- 血中乙氨基酸细胞数量和EDN水平显示为严重喘中生物治疗反应的预测标志物具有前景.
- 需要进一步的研究来验证EDN作为喘生物标志物的可靠性和适用性.
关键词:
过敏性炎症是一种过敏性炎症.喘 喘 是一种生物疗法 生物疗法生物标志物生物标志物血液中埃索诺菲尔细胞的数量埃索诺菲尔衍生的神经毒素来自于埃索诺菲尔.埃索诺菲尔细胞是什么意思恶化的速度加剧.肺功能 肺功能 肺功能更多相关视频
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
02:06Allergic Reactions
27.2K
Overview
27.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
233
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
233